These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32961071)

  • 1. Primary immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2008-2017.
    Che X; Liu Y; Wang J; Xu Y; Zhang X; Gu W; Jiang W; Du J; Zhang X
    Hum Vaccin Immunother; 2021 Apr; 17(4):1239-1243. PubMed ID: 32961071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Booster immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2014-2019.
    Che X; Liu Y; Wang J; Xu Y; Zhang X; Gu W; Jiang W; Du J; Zhang X
    PLoS One; 2021; 16(5):e0251567. PubMed ID: 34032806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation on meningococcal vaccination strategies among children under nine years of age in Zhejiang province, China.
    Shen J; Ji C; Luo X; Hu Y
    PLoS One; 2024; 19(9):e0310274. PubMed ID: 39250492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of vaccination strategies against meningococcal disease for children under nine years of age in China.
    Zhang H; Zhang H; Fang H
    Hum Vaccin Immunother; 2024 Dec; 20(1):2313872. PubMed ID: 38348600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children.
    Sow SO; Tapia MD; Haidara FC; Diallo F; Traore Y; Traoré A; Kodio M; Borrow R; Townsend-Payne K; Yuan L; Yang S; Shi L; Chen J; Fang G; Lin J; Hu R; Viviani S; Huang Z
    Hum Vaccin Immunother; 2023 Aug; 19(2):2230829. PubMed ID: 37401618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization.
    Meyer SA; Kambou JL; Cohn A; Goodson JL; Flannery B; Medah I; Messonnier N; Novak R; Diomande F; Djingarey MH; Clark TA; Yameogo I; Fall A; Wannemuehler K
    Vaccine; 2015 Mar; 33(12):1492-8. PubMed ID: 25636915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014.
    Liu Y; Wang J; Liu S; Du J; Wang L; Gu W; Xu Y; Zuo S; Xu E; An Z
    Vaccine; 2017 Mar; 35(9):1281-1286. PubMed ID: 28161421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination pattern of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Hangzhou, China: a coverage and adverse events following immunization of different age groups.
    Liu Y; Xu Y; Wang J; Che X; Gu W; Du J; Zhang X; Zhang X; Jiang W; Chen J; An Z
    Hum Vaccin Immunother; 2021 Jan; 17(1):157-161. PubMed ID: 32530728
    [No Abstract]   [Full Text] [Related]  

  • 9. Meningococcal invasive disease by serogroup W and use of ACWY conjugate vaccines as control strategy in Chile.
    Villena R; Valenzuela MT; Bastías M; Santolaya ME
    Vaccine; 2019 Oct; 37(46):6915-6921. PubMed ID: 31585728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
    McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
    Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experts' consensus on immunization with meningococcal vaccines in China].
    Chinese Preventive Medicine Association
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Feb; 40(2):123-128. PubMed ID: 30744259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal vaccines in China.
    Xu Y; Li Y; Wang S; Li M; Xu M; Ye Q
    Hum Vaccin Immunother; 2021 Jul; 17(7):2197-2204. PubMed ID: 33566720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experts' consensus on immunization with meningococcal vaccines in China].
    Chinese Preventive Medicine Association
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Feb; 53(2):141-145. PubMed ID: 30744286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of meningococcal (Groups A and C) polysaccharide vaccine in children 2 to 6 y of age in China: a randomized, active-controlled, non-inferiority study.
    Zhu FC; Hu YM; Li YN; Shu JD; Oster P
    Hum Vaccin Immunother; 2021 Mar; 17(3):919-926. PubMed ID: 33270487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Present situation and new perspectives for vaccination against Neisseria meningitidis in Tuscany, Central Italy.
    Bechini A; Levi M; Boccalini S; Tiscione E; Ceccherini V; Taddei C; Balocchini E; Bonanni P
    J Prev Med Hyg; 2012 Jun; 53(2):61-7. PubMed ID: 23240162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving meningococcal immunization strategies.
    Sáfadi MA; Bettinger JA; Maturana GM; Enwere G; Borrow R;
    Expert Rev Vaccines; 2015 Apr; 14(4):505-17. PubMed ID: 25494168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global practices of meningococcal vaccine use and impact on invasive disease.
    Ali A; Jafri RZ; Messonnier N; Tevi-Benissan C; Durrheim D; Eskola J; Fermon F; Klugman KP; Ramsay M; Sow S; Zhujun S; Bhutta Z; Abramson J
    Pathog Glob Health; 2014 Jan; 108(1):11-20. PubMed ID: 24548156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis for protection rate and antibody levels of epidemic cerebrospinal meningitis among children aged between 3-23 months in Liuzhou, in 2012].
    Cui XL; Wu X; Li MQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1079-1083. PubMed ID: 28057112
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the Impact of Meningococcal Serogroup A Conjugate Vaccine Introduction on Second-Year-of-Life Vaccination Coverage in Burkina Faso.
    Zoma RL; Walldorf JA; Tarbangdo F; Patel JC; Diallo AO; Nkwenkeu SF; Kambou L; Nikiema M; Ouedraogo A; Bationo AB; Ouili R; Badolo H; Sawadogo G; Krishnaswamy A; Hatcher C; Hyde TB; Aké F; Novak RT; Wannemuehler K; Mirza I; Medah I; Soeters HM
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S233-S243. PubMed ID: 31671442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
    Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
    Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.